150 related articles for article (PubMed ID: 37926574)
41. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
[TBL] [Abstract][Full Text] [Related]
42. Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning.
Zhao Y; Wu P; Wu J; Brendel M; Lu J; Ge J; Tang C; Hong J; Xu Q; Liu F; Sun Y; Ju Z; Lin H; Guan Y; Bassetti C; Schwaiger M; Huang SC; Rominger A; Wang J; Zuo C; Shi K
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2798-2811. PubMed ID: 35588012
[TBL] [Abstract][Full Text] [Related]
43. Identification of Parkinson's disease and multiple system atrophy using multimodal PET/MRI radiomics.
Sun J; Cong C; Li X; Zhou W; Xia R; Liu H; Wang Y; Xu Z; Chen X
Eur Radiol; 2024 Jan; 34(1):662-672. PubMed ID: 37535155
[TBL] [Abstract][Full Text] [Related]
44. FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice.
Arnone A; Allocca M; Di Dato R; Puccini G; Laghai I; Rubino F; Nerattini M; Ramat S; Lombardi G; Ferrari C; Bessi V; Sorbi S; De Cristofaro MT; Polito C; Berti V
Neurol Sci; 2022 Sep; 43(9):5333-5341. PubMed ID: 35697965
[TBL] [Abstract][Full Text] [Related]
45. Dopamine transporter SPECT imaging in Parkinson's disease and atypical Parkinsonism: a study of 137 patients.
Constantinides VC; Souvatzoglou M; Paraskevas GP; Chalioti M; Stefanis L; Kapaki E
Neurol Sci; 2023 May; 44(5):1613-1623. PubMed ID: 36658411
[TBL] [Abstract][Full Text] [Related]
46. Multiple System Atrophy: Phenotypic spectrum approach coupled with brain 18-FDG PET.
Grimaldi S; Boucekine M; Witjas T; Fluchère F; Renaud M; Azulay JP; Guedj E; Eusebio A
Parkinsonism Relat Disord; 2019 Oct; 67():3-9. PubMed ID: 31621603
[TBL] [Abstract][Full Text] [Related]
47. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
[TBL] [Abstract][Full Text] [Related]
48. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
Lyoo CH; Jeong Y; Ryu YH; Lee SY; Song TJ; Lee JH; Rinne JO; Lee MS
Brain; 2008 Feb; 131(Pt 2):438-46. PubMed ID: 18178568
[TBL] [Abstract][Full Text] [Related]
49. Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
Ko JH; Lee CS; Eidelberg D
J Cereb Blood Flow Metab; 2017 Feb; 37(2):683-693. PubMed ID: 26980757
[TBL] [Abstract][Full Text] [Related]
50. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
Carli G; Meles SK; Reesink FE; de Jong BM; Pilotto A; Padovani A; Galbiati A; Ferini-Strambi L; Leenders KL; Perani D
Neuroimage Clin; 2023; 39():103475. PubMed ID: 37494757
[TBL] [Abstract][Full Text] [Related]
51. Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.
Kaasinen V; Kankare T; Joutsa J; Vahlberg T
J Nucl Med; 2019 Dec; 60(12):1757-1763. PubMed ID: 30979821
[TBL] [Abstract][Full Text] [Related]
52. Different loss of dopamine transporter according to subtype of multiple system atrophy.
Kim HW; Kim JS; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Lee CS
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):517-25. PubMed ID: 26384682
[TBL] [Abstract][Full Text] [Related]
53. Distinct clinical features of predominant pre-synaptic and trans-synaptic nigrostriatal dysfunction in multiple system atrophy.
Ryu HS; Oh M; Oh JS; Moon H; Park KW; Lee C; You S; Kim MJ; Kim YJ; Kim J; Kim K; Kim JS; Chung SJ
J Neurol Sci; 2019 Jul; 402():100-106. PubMed ID: 31128455
[TBL] [Abstract][Full Text] [Related]
54. In vivo cerebral metabolic and dopaminergic characteristics in multiple system atrophy with orthostatic hypotension.
Xue C; Dou X; Yu C; Zhong Y; Wang J; Zhang X; Xue L; Hu D; Wu S; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):468-480. PubMed ID: 37807003
[TBL] [Abstract][Full Text] [Related]
55. Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.
Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Kim JS
Clin Nucl Med; 2017 Feb; 42(2):e80-e87. PubMed ID: 27922865
[TBL] [Abstract][Full Text] [Related]
56. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.
Gilman S; Koeppe RA; Nan B; Wang CN; Wang X; Junck L; Chervin RD; Consens F; Bhaumik A
Neurology; 2010 May; 74(18):1416-23. PubMed ID: 20439843
[TBL] [Abstract][Full Text] [Related]
57. Multivariate radiomics models based on
Hu X; Sun X; Hu F; Liu F; Ruan W; Wu T; An R; Lan X
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3469-3481. PubMed ID: 33829415
[TBL] [Abstract][Full Text] [Related]
58. Reproducible metabolic topographies associated with multiple system atrophy: Network and regional analyses in Chinese and American patient cohorts.
Shen B; Wei S; Ge J; Peng S; Liu F; Li L; Guo S; Wu P; Zuo C; Eidelberg D; Wang J; Ma Y
Neuroimage Clin; 2020; 28():102416. PubMed ID: 32987300
[TBL] [Abstract][Full Text] [Related]
59. Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
Tripathi M; Tang CC; Feigin A; De Lucia I; Nazem A; Dhawan V; Eidelberg D
J Nucl Med; 2016 Jan; 57(1):60-6. PubMed ID: 26449840
[TBL] [Abstract][Full Text] [Related]
60. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
